When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Vaccinex's pepinemab shows encouraging action in treatment-resistant lung cancer
Pfizer Inc.
Updated data from a Phase 1b/2 clinical trial, CLASSICAL-Lung, evaluating the combination of Vaccinex's (NASDAQ:VCNX) lead candidate pepinemab and Pfizer (NYSE:PFE) and Merck KGaA's (OTCPK:MKGAF) Bavencio (avelumab) in patients with treatment-resistant advanced non-small cell lung cancer (NSCLC) showed a positive effect. The results were presented at the International Cancer lmmunotherapy Conference in Paris.
More news on: Vaccinex, Inc., Pfizer Inc., MERCK Kommanditgesellschaft auf Aktien, Healthcare stocks news,